Article: Microbial Process Development For BioPharmaceuticals
From Science and Engineering to Regulatory Requirements
Longze Cui
Microbial expression systems play an essential role in today's biopharmaceutical processes. Recombinant E. coli and yeast systems are dominant tools in early discovery of effective medical targets. These systems are also routinely used to produce biological reagents for analytical methods in research and quality controls of products. In the biopharmaceutical industry, microbial systems have delivered major medicines such as blood protein (factors VIII and IX), G-CSF, tPA, recombinant hepatitis B vaccine, interferons, interleukins, and human growth hormone.
Reprinted with permission from BioProcess International 2(6): pp 32-39 (June 2004) Click Here To Download:Article: Microbial Process Development For BioPharmaceuticals



